ABSTRACT Seventy four cases of thymoma were reclassified into three histological categoriescortical (30), medullary (9), and mixed (34) (the remaining patient had an intrathymic thymoma)-for an investigation of the relation between histological type, clinical behaviour, and long term prognosis. There were significant differences between the histological types in the frequency of myasthenia gravis and of the different tumour stages, the mean age of the patients, and prognosis. Myasthenia gravis occurred more commonly in patients with cortical (33%) and mixed thymoma (35%) than in patients with medullary thymoma (11%). Five, 10, 15, and 20 year actuarial survival was 100% for medullary thymoma; 85%, 76%, 65% and 65% respectively for mixed thymoma; and 52%, 45%, 45%, and 45% for cortical thymoma. Medullary thymoma is a benign tumour arising late in life and there was no mortality in this series after surgery alone. Cortical thymoma usually presented in middle age and must be regarded as malignant; mortality was 50% at five years despite a multidisciplinary approach, with surgery and postoperative radiotherapy in all patients and chemotherapy in selected cases. Mixed thymoma had a better prognosis than cortical thymoma, but must be regarded as potentially malignant. One third ofthe total patients had died by 10 years despite radical tumour resection.
Introduction Methods
Thymomas, defined as thymic epithelial neoplasms with minimal or no cytological atypia,' are chara.zterised by a remarkable morphological heterogeneity2 and variable clinical behaviour.34 Histological classifications in current use are based purely on morphology245 and have little prognostic or therapeutic value. In consequence, treatment is at present based solely on the surgical stage.
The classification recently proposed by Marino and Muiller-Hermelink6 takes both morphology and histogenesis into account, and provides a new approach to management. In a preliminary investigation' we found that the classification correlated well with the surgical stage of the tumour. In the present study we have analysed the relation between clinical features, long term prognosis, and histological type in a larger group of patients.
From January 1965 to December 1987 120 patients with thymoma were treated surgically in the department of surgery ofthe University of Rome. In 38 cases insufficient pathological material was available for review, and eight patients were lost to follow up. The remaining 74 cases form the basis ofthis investigation.
Sections 4 gm thick were stained for conventional histological examination with haematoxylin and eosin and the Giemsa, periodic acid-Schiff, and Gomori techniques, and examined by the same pathologists (CDB, EOP, LPR), all of whom have specific experience in the subject. Invasiveness was graded according to the criteria of Masaoka.8 was given routinely to patients with stage III and IV disease, and chemotherapy was combined with radiotherapy in three patients with stage 4 disease.
Radical resection was possible in 60 of the 74 cases; palliative resection was performed in six and biopsy alone in eight. All patients with medullary thymomas underwent radical resection, whereas in 10 of the 30 patients with cortical thymoma and in four of 34 with mixed thymoma only palliative surgery or biopsy was possible.
All patients with medullary thymoma are alive two to 22 years after surgery; for those with mixed and cortical thymoma the prognosis was significantly worse, with actuarial survival rates of65% and 45% at 20 years (table 3 and fig 4) . Six patients with stage I or II cortical or mixed thymoma died of the disease. All of the patients with relapsing disease that required further surgery had a cortical thymoma; three had stage III or IV tumours and had undergone radiotherapy after the first operation. In two patients stage II lesions were present and no radiotherapy was administered. One patient with medullary thymoma was followed by computed tomography for five years ( fig 5) ; the tumour remained localised throughout this period. 
